<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03916536</url>
  </required_header>
  <id_info>
    <org_study_id>Prostate Enucleation</org_study_id>
    <nct_id>NCT03916536</nct_id>
  </id_info>
  <brief_title>Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate.</brief_title>
  <official_title>Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate for Treatment of Large Sized Benign Prostatic Enlargement. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Because of the diversity of the studies and deficiency of those comparing various techniques
      of EEP for treatment of LUTs secondary to BPO in patients with large sized prostate, we aim
      in this study at testing the non-inferiority of PKEP and ThuLEP to HoLEP in relieving LUTs
      secondary to BPO in patients prostate size &gt;80ml. Our hypothesis is to present an evidence
      that enucleation is a technique rather than a power dependent procedure through a RCT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urinary functional outcomes using uroflowmetry</measure>
    <time_frame>2 years</time_frame>
    <description>assessed by maximum flow rate (Q-max) measured using uroflowmetry by ml/sec, better outcome above 15ml/sec</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient symptoms</measure>
    <time_frame>2 years</time_frame>
    <description>assessed by international prostate symptoms score (IPSS) questionnaire, better outcome score below 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perioperative complications</measure>
    <time_frame>2 years</time_frame>
    <description>assessed by clavien dindo score</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Prostate Hypertrophy</condition>
  <condition>Holmium Laser</condition>
  <condition>Thulium Laser</condition>
  <condition>Bipolar Diathermy</condition>
  <condition>Prostate Enucleation</condition>
  <arm_group>
    <arm_group_label>Holmium Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>holmium laser enucleation of the prosteate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thulium Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thulium laser enucleation of the prosteate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bipolar Enucleation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bipolar enucleation of the prosteate</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Holmium Laser</intervention_name>
    <description>Holmium laser enucleation of large sized prostate</description>
    <arm_group_label>Holmium Laser</arm_group_label>
    <other_name>HoLEP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thulium Laser</intervention_name>
    <description>Thulium laser enucleation of large sized prostate</description>
    <arm_group_label>Thulium Laser</arm_group_label>
    <other_name>ThuLEP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bipolar diathermy</intervention_name>
    <description>Bipolar enucleation of large sized prostate</description>
    <arm_group_label>Bipolar Enucleation</arm_group_label>
    <other_name>Bipolar enucleation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients' age &gt;50 years

          -  Lower urinary tract symptoms LUTS secondary benigh prostatic obstruction BPO who
             failed medical treatment

          -  International prostate symptom scores (IPSS) &gt;15 and bother score quality of life
             (QOL) &gt; 3 (according to IPSS question 8)

          -  Maximum urinary flow rate (Q max) &lt;15 ml/sec with at least 150 ml voided volume or
             cases with acute urine retention secondary to BPO who failed trial of voiding on
             medical treatment.

          -  Transrectal ultrasound TRUS estimated total prostate size 80-250cc

        Exclusion Criteria:

          -  Patient with neurological disorder which might affect bladder function as
             cerebrovascular stroke, Parkinson disease

          -  Active urinary tract infection (positive urine culture) till treatment

          -  Presence of bladder cancer (within the last 2 years)

          -  Known prostate cancer patients will be excluded preoperatively on the basis of digital
             rectal examination, prostate specific antigen level, and TRUS imaging followed by
             prostate biopsies if necessary.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>male</gender_description>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fady Ghobrial, Msc</last_name>
    <phone>00201024974979</phone>
    <email>dr_fadykamal@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Shoma, MD</last_name>
      <email>ahmedshoma@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 13, 2019</study_first_submitted>
  <study_first_submitted_qc>April 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Fady kamal Ghobrial</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Holmium Laser</keyword>
  <keyword>Thulium Laser</keyword>
  <keyword>Bipolar diathermy</keyword>
  <keyword>prostate enucleation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

